Protagenic Therapeutics, Inc.\new (PTIX) Operating cash flow 2018–2026
Protagenic Therapeutics, Inc.\new (PTIX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.8MFY2026 · since FY2018: -$1.4M → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2.8M | -58.7% |
| FY2025 | -$1.8M | +52.2% |
| FY2024 | -$3.7M | -85.8% |
| FY2023 | -$2.0M | +28.8% |
| FY2022 | -$2.8M | -107.5% |
| FY2021 | -$1.3M | -176.4% |
| FY2020 | -$487,990 | +54.4% |
| FY2019 | -$1.1M | +22.4% |
| FY2018 | -$1.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice